Innovative MedTech Inc.
IMTH · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.04 | 0.11 | 0.02 |
| FCF Yield | -2.18% | -1.56% | -1.09% | 0.98% |
| EV / EBITDA | -1.67 | -4.05 | -3.37 | -1.51 |
| Quality | ||||
| ROIC | 238.90% | -152.86% | -756.12% | -19.36% |
| Gross Margin | 96.38% | 96.70% | 94.61% | 97.24% |
| Cash Conversion Ratio | 0.02 | 0.05 | 0.03 | -0.01 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.03% | 70.32% | – | – |
| Free Cash Flow Growth | -28.77% | 71.15% | -2,339.29% | 157.06% |
| Safety | ||||
| Net Debt / EBITDA | -0.27 | -0.60 | -0.11 | -0.59 |
| Interest Coverage | -21.47 | -16.34 | -95.36 | -4.12 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | -2.57 | 0.00 |
| Cash Conversion Cycle | -7,249.82 | -6,943.76 | -7,987.87 | -26,202.32 |